IRCT2017071935175N1已完成未知
Evaluating silymarin effects on cardiac and hepatic side effects of chemotherapy drug in children with acute lymphoblastic leukemia
Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 14 years（—）
- 性别
- All
入选标准
- •Diagnosis of ALL based on bone marrow morphology and immunophenotype; Age 2-14 years; Therapy in maintenance phase of childhood ALL (at least 6 months);
- •Exclusion criteria: Previous history of liver and heart disease; Take any other medicines except chemotherapy drug
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
已完成
3 期
Evaluation of the effect of silymarin on hepatotoxicity induced by RemdesivirCOVID-19.COVID-19, virus identifiedU07.1IRCT20201227049854N1Shahre-kord University of Medical Sciences70
已完成
4 期
The effect of silymarin on Alzheimer’s diseasesAlzheimer disease.Alzheimer's diseaseIRCT20131219015870N3Faculty of Pharmaceutical Sciences, Islamic Azad University of Medical Sciences, Tehran22
已完成
不适用
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugsDrug induced hepatitis by anti tuberculosis.Antimycobacterial drugsIRCT138903294209N1ational Institute of tuberculosis and lung disease60
已完成
1 期
Evaluation of the effect of silymarin on blood sugar profile(FBSand 2hpp ) and HbA1C in patients with type 2 diabetes mellitusIRCT20170814035697N5Oroumia University of Medical Sciences50